Adenovirus isolates from urine of patients with acquired immunodeficiency syndrome. NLM AIDSLINE Important note: Information in this article was accurate in 1983. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Adenovirus isolates from urine of patients with acquired immunodeficiency syndrome.

Lancet. 1983 Jun 11;1(8337):1293-6. Unique Identifier : AIDSLINE MED/83217893
de Jong PJ; Valderrama G; Spigland I; Horwitz MS


Abstract: 13 adenoviruses (Ad) from the urine of 10 patients with acquired immunodeficiency syndrome (AIDS) were characterised by haemagglutination inhibition and restriction endonuclease analysis of their DNA. The haemagglutinin (HA) for 6 of these isolates was found to be that of Ad34/35. 3 other isolates were found to have Ad7 HA and the remaining 4 viruses were found to have both phenotypes. In contrast, the restriction patterns were more homogeneous than anticipated from the serological analysis. 11 isolates had a SmaI-restriction pattern identical to Ad35, and 2 isolates, which lacked one of the 9 Ad35 SmaI-restriction sites, were identical to Ad34. Analyses with other restriction enzymes reinforced the conclusion that the genomes of all isolates resemble that of Ad35 (and Ad34) more than they resembled the previously isolated Ad7 subtypes. The discrepancy between the restriction endonuclease and the serological analyses is best explained by assuming that some of these new isolates are recombinants between a small part (less than 10%) of the Ad7 genome coding for HA and greater than 90% of the Ad35 genome. It is therefore important to characterise both the genotype and the HA for this potentially important group of pathogens in AIDS patients.
Keywords: Acquired Immunodeficiency Syndrome/*MICROBIOLOGY Adenoviridae/CLASSIFICATION/GENETICS/*ISOLATION & PURIF DNA Restriction Enzymes/METABOLISM Female Genotype Hemagglutination Inhibition Tests Hemagglutination, Viral Hemagglutinins, Viral/GENETICS Human Male Phenotype Recombination, Genetic Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Urine/*MICROBIOLOGY JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDmicrobiologyadenoviridae/classification/genetics/KWDisolation&purifdnarestrictionenzymes/metabolismfemalegenotypehemagglutinationinhibitiontestshemagglutination,viralhemagglutinins,viral/geneticshumanmalephenotyperecombination,geneticsupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDurine/KWDmicrobiologyjournalarticle
830930
M8390004


Copyright © 1983 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1983. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1983. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .